Bacteriophage manipulation of the microbiome associated with tumour microenvironments-can this improve cancer therapeutic response?

Keyphrases

• Microbiome 100%
• Bacteriophage 100%
• Tumor Microenvironment 100%
• Therapeutic Response 100%
• Cancer Therapeutics 100%
• Oncobacterium 100%
• Tumor Microbiome 75%
• Relative Abundance 50%
• Tumor Tissue 50%
• Tissue Microbiome 50%
• Inflammatory Cytokines 25%
• Microorganisms 25%
• Cancer Cells 25%
• Treatment Efficacy 25%
• Antibiotics 25%
• Cancer Therapy 25%
• Biofilm 25%
• Bacterial Growth 25%
• Fusobacterium 25%
• Cancer Treatment 25%
• Treatment Failure 25%
• Specific Bacteria 25%
• Antimicrobial Resistance 25%
• Cancer Growth 25%
• Lytic Bacteriophage 25%
• Microbiome Manipulation 25%
• Streptococcus Species 25%
• Treponema Species 25%
• Prevotella Species 25%
• Peptostreptococcus 25%
• Parvimonas 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Microbiome 100%
• Tumor Microenvironment 100%
• Bacteriophage 100%
• Neoplasm 83%
• Microflora 33%
• Cytokine 16%
• Combination Therapy 16%
• Antibiotics 16%
• Fusobacterium 16%
• Cancer Growth 16%
• Streptococcus 16%
• Antimicrobial Resistance 16%
• Treponema 16%
• Parvimonas 16%
• Prevotella 16%
• Peptostreptococcus 16%
• Antibiotic Resistance 16%

Immunology and Microbiology

• Microbiome 100%
• Bacteriophage 100%
• Microflora 33%
• Antimicrobial Resistance 16%
• Cancer Cell 16%
• Proinflammatory Cytokine 16%
• Biofilm 16%
• Fusobacterium 16%
• Streptococcus 16%
• Bacterial Growth 16%
• Treponema 16%
• Peptostreptococcus 16%
• Parvimonas 16%
• Prevotella 16%